Analyst Ratings for Silverback Therapeutics (SBTX)

SBTX Rating Summary

  |   Expand Research on SBTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/4/2022 Goldman Sachs Paul Choi Downgrade Neutral
(Buy)		 3.50
(25.00)		 3.51
(5.87)		 67.24% Details
4/1/2022 Jones Trading Soumit Roy Downgrade Hold
(Buy)		 N/A
(N/A)		 3.51
(5.87)		 67.24% Details